Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7375 p596
12 November 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Confidentiality for under 16s challenged in High Court

This week, a mother challenged Department of Health guidelines on confidentiality at a judicial review in the High Court. The DoH guidelines state that girls under 16 years can receive advice on contraception and have a termination without their parents' knowledge.

Anne Weyman, chief executive of the fpa (Family Planning Association), says that if confidentiality is removed it will deter teenagers from seeking advice on sexual health. “This case seeks to compel health professionals to inform the parents of anyone aged under 16 that they have been approached by that young person for advice, information or treatment about any sexual health matter, not just abortion,” she said.

Lynsey Balmer, head of professional ethics at the Royal Pharmaceutical Society, commented: “Existing guidance about confidentiality in the Society’s Code of Ethics and Standards says that ‘information about services provided to adolescents should not normally be disclosed to their parents’. It details some exceptional circumstances, for example, to prevent serious injury or damage to the health of a patient. The Society is looking to develop further guidance relating to under 16s, sexual health and confidentiality.”

Ms Weyman highlights that current Government guidance already makes it clear that health professionals should encourage young people to involve their parents or ask if they may inform them on their behalf.

The case was due to be heard from 8–10 November; a date has not been set for the judgment.

Back to Top


©The Pharmaceutical Journal